Hantavirus immunology

Viral Immunology

Volumn 15, Issue 4, 2002, Pages 609-625

  Khaiboullina, Svetlana F ^a   St Jeor, Stephen C ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIBODY RESPONSE; CROSS REACTION; ENDOTHELIUM CELL; HANTAVIRUS; HEMORRHAGIC FEVER; HUMAN; IMMUNE SYSTEM; KIDNEY DISEASE; LUNG DISEASE; MICROVASCULATURE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REVIEW; SYNDROME DELINEATION; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM; VIRUS INFECTION;

HANTAVIRUS; RNA VIRUSES;

EID: 0036449533     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282402320914548     Document Type: Review

References (165)

1. Abbas, A.K., A.H. Lichtman, and J.S. Pober. 1997. Cytokines, pp. 249-278. In Cellular and Molecular Immunology, 3rd Ed. Sanders, Philadelphia.
2. Abe, Y., S. Sekiya, T. Yamasita, et al. 1990. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody. J. Immunol. 145:2902-2907.
3. Agostini, C., L. Trentin, R. Zambello, et al. 1992. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J. Immunol. 149:3379-3385.
4. Alexeyev, O.A. 1991. Two cases of hyperimmunoglobulinemia E in patients with hemorrhagic fever with renal syndrome. Scand. J. Infect. Dis. 23:391.
5. Alexeyev, O.A., C. Ahlm, J. Billheden, et al. 1994. Elevated levels of total and Puumala virus-specific immunoglobulin E in the Scandinavian type of hemorrhagic fever with renal syndrome. Clin. Diagn. Lab. Immunol. 1:269-272.
6. Allavena, P., G. Bianchi, D. Zhou, et al. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24:3233-3236.
7. Arikawa, J., A.L. Schmaljohn, J.M. Dalrymple, et al. 1989. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 70:615-624.
8. Asada, H., M. Tamura, K. Kondo, et al. 1987. Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice. J. Gen. Virol. 68:1961-1969.
9. Asada, H., M. Tamura, K. Kondo, et al. 1988. Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: Generation of cytotoxic T lymphocytes. J. Gen. Virol. 69:2179-2188.
10. Asano, Y., Y. Hiroishi, N. Hirose, et al. 1987. Immonoglobulin subclass antibodies to Varicella-zoster. Pediatrics 80:933-936.
11. Asano, Y., Y. Hiroishi, N. Itukara, et al. 1988. Placental transfer of IgG subclass-specific antibodies to Varicellazoster virus. J. Med. Virol. 26:1-6.
12. Avsic-Zupanc, T., M. Petrovec, P. Furlan, et al. 1999. Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia - A 10-year survey. Clin. Infect. Dis. 28:860-865.
13. Barber, G.N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126.
14. Bharadwaj, M., R. Nofchissey, D. Goade, et al. 2000. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis. 182:43-48.
15. Bernshtein, A.D., N.S. Apekina, T.V. Mikhailova, et al. 1999. Dynamics of Puumala hantavirus infection in naturally infected bank voles (Clethrinomys glareolus). Arch. Virol. 144:2415-2428.
16. Beverley, P.C. 1990. Is T-cell memory maintained by crossreactive stimulation? Immunol. Today 11:203-205.
17. Bless, N.M., M. Huber-Lang, R.F. Guo, et al. 2000. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J. Immunol. 164:2650-2659.
18. Bogdanov, S.B., I.N. Gavrilivskaya, V.A. Boyko, et al. 1987. Persistent infection of caused by haemorrhagic fever with renal syndrome virus in bank voles (Cletrionomys glareolus) - The natural host of the virus. Mikrobiologichskii Zhurnal. 49:99-106.
19. Bostic, P., J. Winter, T.G. Ksiazek, et al. 2000. Sin Nombre virus (SNV) Ig isotope antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg. Infect. Dis. 6:184-187.
20. Borucki, M.K., J.D. Boone, J.E. Rowe, et al. 2000. Role of maternal antibody in natural infection of Peromyscus maniculatus with Sin Nombre virus. J. Virol. 74:2426-2429.
21. Chu, Y.K., G.B. Jennings, and C.S. Schmaljohn. 1995. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 69:6417-6423.
22. Chu, Y.K., G. Jennings, A. Schmaljohn, et al. 1995. Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. J. Infect. Dis. 172:1581-1584.
23. Huang, C., B. Jin, M. Wang, et al. 1994. Hemorrhagic fever with renal syndrome: Relationship between pathogenesis and cellular immunity. J. Infect. Dis. 169:868-870.
24. Chollet-Martin, S., P. Montravers, C. Gibert, et al. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immunol. 61:4553-4559.
25. Conti, P., X. Pang, W. Boucher, et al. 1997. Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. Int. Immunol. 9:1563-1570.
26. Coulson, B.S., K. Grimwood, P.J. Masendyzc, et al. 1990. Comparison of rotavirus immunoglobulin A copro-conversion with other indices of rotavirus infection in a longitudinal study in childhood. J. Clin. Microb. 28:1367-1374.
27. Coutelier, J., J.T.M. van der Logt, F.W.A. Heessen, et al. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64-69.
28. Dantas, J.R., Jr., Y. Okuno, H. Asada, et al. 1986. Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151:379-384.
29. de Carvalho Nicacio, C., E. Bjorling, and A. Lundkvist. 2000. Immunoglobulin A response to Puumala hantavirus. J. Gen. Virol. 81:1453-1461.
30. de Carvalho Nicacio, C., M. Sallberg, C. Hultgren, et al. 2001. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model. J. Gen. Virol. 82:129-138.
31. Dobrogowska, D.H., A.S. Lossinsky, M. Tarnawski, et al. 1998. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 27:163-173.
32. Dohmae, K., U. Koshimizu, and Y. Nishimune. 1993. In utero and mammary transfer of hantavirus antibody from dams to infant rats. Lab. Anim. Sci. 43:557-561.
33. Dohmae, K., and Y. Nishimune. 1995. Protection against hantavirus infection by dam's immunity transferred vertically to neonates. Arch. Virol. 140:165-172.
34. Dohmae, K., and Y. Nishimune. 1998. Maternal transfer of Hantavirus antibodies in rats. Lab. Anim. Sci. 48:395-397.
35. Duchin J.S., F.T. Koster, C.J. Peters, et al. 1994. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330:949-955.
36. Dvorak, H.F., L.F. Brown, M. Detmar, et al. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
37. Elgh, F., A. Lundkvist, O.A. Alexeyev, et al. 1997. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J. Clin. Microb. 35:1122-1130.
38. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531-1536.
39. + cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238:380-390.
40. Enria, D.A., A.M. Briggiler, N. Pini, et al. 2001. Clinical manifestations of New World hantaviruses. CTMI 256:117-134.
41. Feletou, M., J. Staczek, and J. Duhault. 2001. Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch. Br. J. Pharmacol. 132:1342-1348.
42. Ferrara, N., and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocrinol. Rev. 18:4-25.
43. Forthal, D.N., G. Landucci, A. Habis, et al. 1994. Measles virus-specific functional antibody responses and viremia during acute measeles. J. Infect. Dis. 169:1377-1380.
44. Friedman, M.G., M. Phillip, and R. Dagan. 1989. Virus-specific IgA in serum, saliva, and the tears of children with measles. Clin. Exp. Immunol. 75:58-63.
45. Gautam, N., P. Hedqvist, and L. Lindbom. 1998. Kinetics of leukocyte-induced changes in endothelial barrier function. Br. J. Pharmacol. 125:1109-1114.
46. Gautam, N., H. Herwald, P. Hedqvist, et al. 2000. Signaling via beta2 integrins triggers neutrophil-dependent alteration in endothelial barrier function. J. Exp. Med. 191:1829-1839.
47. Gossgrif, T.M. 1991. Mechanisms of disease in hantavirus infection: Pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13:97-107.
48. Gosgriff, T.M., and R.M. Lewis. 1991. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int. 40:S72-S79.
49. Greissman, S.E. 1957. Capillary observations in patients with hemorrhagic fever and other infectious illnesses. J. Clin. Invest. 36:1688-1700.
50. Griffin, D.E.S., J. Cooper, L. Hirsh, et al. 1985. Changes in plasma levels during complicated and uncomplicated measles virus infections. J. Allergy Clin. Immunol. 76:206-213.
51. Groen, J., J. Dalrymple, S. Fisher-Hoch, et al. 1992. Serum antibodies to structural proteins of Hantavirus arise at different times after infection. J. Med. Virol. 37:283-287.
52. Groen, J., M. Gerding, J.G.M. Jordans, et al. 1994. Class and subclass distribution of hantavirus-specific serum antibodies at different times after the oncet of nephropatia epidemica. J. Med. Virol. 43:39-43.
53. Groen, J., M. Gerding, J.P. Koeman, et al. 1995. A macaque model for hantavirus infection. J. Infect. Dis. 172:38-44.
54. Gu, X.S., Z.Q. You, and G.R. Meng. 1989. Hemorrhagic fever with renal syndrome: Separation of human peripheral blood T and B cells and detection of viral antigen. Mater. Med. Pol. 21:103-105.
55. Guidotti, L.G., and F.V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
56. Hashido, N., and T. Tawana. 1997. Herpes simplex virus-specific IgM, IgA and IgG subclass antibody responses in primary and nonprimary genital herpes patients. Microb. Immunol. 41:415-420.
57. Hjelle, B., S.-W. Lee, W. Song, et al. 1995. Molecular linkage of hantavirus pulmonary syndrome to white-footed mouse, Peromyscus leucopus: Genetic characterization of the M genome of New York Virus. J. Virol. 69:8137-8141.
58. Horling, J., A. Lundkvist, J.W. Huggins, et al. 1992. Antibodies to Puumala virus in humans determined by neutralization test. J. Virol Methods. 39:139-147.
59. Horling, J., A. Lundkvist, K. Persson, et al. 1995. Detection and subsequent sequencing of Puumala virus from human speciments by PCR. J. Clin. Microb. 33:277-282.
60. Horvath, C.J., T.J. Ferro, G. Jesmok, et al. 1988. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc. Natl. Acad. Sci. U.S.A. 85:9219-9223.
61. Israel-Biet, D., F. Labrousse, J.-M. Tourani, et al. 1992. Elevation of IgE in HIV-infected subjects: A marker of poor prognosis. J. Allerg. Clin. Immunol. 89:68-75.
62. Jenison, S., T. Yamada, C. Morris, et al. 1994. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J. Virol. 68:3000-3006.
63. Johansen, K., L. Granqvist, K. Karlen, et al. 1994. Serum IgA immune response to individual rotavirus polyleptides in young children with rotavirus infection. Arch. Virol. 138:247-259.
64. Johnson, C.B., and C.S. Schmaljohn. 2001. Replication of Hantaviruses. CTMI 256:15-32.
65. Johnson, J., K.L. Brigham, G. Jesmok, et al. 1991. Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha. Am. Rev. Respir. Dis. 144:179-186.
66. Johnson, W.J., Z. Steplewski, H. Korpowski, et al. 1985. In P. Herkart, and E. Martz, (eds.) Mechanisms of Cell-mediated Cytotoxicity II. Plenum, New York, pp. 75-80.
67. Juto, P., F. Elgh, C. Ahlm, et al. 1997. The first human isolate of Puumala virus in Scandinavia as cultured from phytohemagglutinin stimulated leucocytes. J. Med. Virol. 53:150-156.
68. Kallio-Kokko, H., O. Vapalahti, K. Hedman, et al. 1993. Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen. J. Clin. Microb. 31:677-680.
69. Kallio-Kokko, H., O. Vapalahti, A. Lundkvist, et al. 1998. Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin. Diagn. Virol. 10:83-90.
70. + T cells expressing NK cell receptors in influenza A virus-infected mice. J. Immunol. 165:4964-4969.
71. Kanerva, M., J. Mustonen, and A. Vaheri. 1998. Pathogenesis of Puumala and other hantavirus infections. Rev. Med. Virol. 8:67-86.
72. Kariwa, H., M. Kamimura, J. Arikawa, et al. 1995. Characterization of the mode of Hantaan virus infection in adult mice using a nested reverse transcriptase polymerase chain reaction: Transient virus replication in adult mice. Microb. Immunol. 39:35-41.
73. Kawai, T., M. Seki, K. Hiromatsu, et al. 1999. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 163:3269-3278.
74. Khaiboullina, S.F., D.M. Netski, P. Krumpe, et al. 2000. Effects of tumor necrosis factor-alpha on Sin Nombre virus infection in vitro. J. Virol. 74:11966-11971.
75. Khaiboullina, S.F., S. Levis, D. Enria, et al. 2001. Cytokine mRNA expression in hantavirus infected cells. Presented at the 5th International Conference on Hemorrhagic Fever with Renal Syndrome (HFRS), Hantavirus Pulmonary Syndrome (HPS), and Hantaviruses. Annecy, France, 13-16 June.
76. Khan, A.S., C.F. Spiropoulou, S. Morzunov, et al. 1995. Fatal illness associated with a new hantavirus in Louisiana. J. Med. Virol. 46:281-286.
77. Khan, A.S., M. Gaviria, P.E. Rollin, et al. 1996. Hantavirus pulmonary syndrome in Florida: Association with the newly identified Black Creek Canal virus. Am. J. Med. 100:46-48.
78. Krakauer, T., J.W. Leduc, and H. Krakauer. 1995. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome. Viral Immunol. 8:75-79.
79. Krishnaswamy, G., J. Kelley, L. Yerra, et al. 1999. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease. J. Interferon Cytokine Res. 19:91-104.
80. Lahdevirta, J. 1971. Nephropathia epidemica in Finland. A clinical, histological and epidemiological study. Ann. Clin. Res. 3:S1-S154.
81. Lahrtz, F., L. Piali, D. Nadal, et al. 1997. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 27:2484-2489.
82. Lee, J.S. 1991. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int. 40:S88-S93.
83. Lee H.W. 1982. Korean hemorrhagic fever. Prog. Med. Virol. 28:96-113.
84. Leek, R.D., N.C. Hunt, R.J. Landers, et al. 2000. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190:430-436.
85. Leung, D.W., G. Cachianes, W.J. Kuang, et al. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
86. Levis, S., S.P. Morzunov, J.E. Rowe, et al. 1998. Genetic diversity and epidemiology of hantaviruses in Argentina. J. Infect. Dis. 177:529-538.
87. Lewis, R.M., H.W. Lee, A.F. See, et al. 1991. Changes in population of immune effector cells during the course of hemorrhagic fever with renal syndrome. Trans. R. Soc. Trop. Med. Hyg. 85:282-286.
88. Linderholm, M., C. Ahlm, B. Settergren, et al. 1996. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173:38-43.
89. Linderholm, M., and F. Elgh. 2001. Clinical characteristics of hantavirus infections on the Eurasian Continent. CTMI 256:135-152.
90. Chen, L., and W. Yang. 1990. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J. Infect. Dis. 161:1016-1019.
91. Lukes, R.J. 1954. The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am. J. Med. 16:201-221.
92. Lundkvist, A., A. Fatouros, and B. Niklasson. 1991. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. J. Gen. Virol. 72:2097-2103.
93. Lundkvist, A., and B. Niklasson. 1992. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: Identification of epitopes involved in neutralization. Arch. Virol. 126:93-105.
94. Lunkvist, A., S. Bjorsten, and B. Niklasson. 1993. Immunoglobulin G subclass responses against the structural components of Puumala virus. J. Clin. Microb. 31:368-372.
95. Lunkvist, A., J. Horling, and B. Niklasson. 1993. The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays. Arch. Virol. 130:121-130.
96. Lundkvist, A., H. Kallio-Kokko, K.B. Sjolander, et al. 1996. Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains in protective immunity. Virology 216:397-406.
97. Lundkvist, A., O. Vapalahti, A. Plyusnin, et al. 1996. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Virus Res. 45:29-44.
98. Lundkvist, A., M. Hukic, J. Horling, et al. 1997. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzogovina: Evidence of highly cross-neutralizing antibody responses in early patient sera. J. Med. Virol. 53:51-59.
99. Mann, D.W., G. Sonnenfeld, and J. Stein-Streilein. 1985. Pulmonary compartmentalization of interferon and natural killer cell activity. Proc. Soc. Exp. Biol. Med. 180:224-230.
100. Matsukawa, A., C.M. Hogaboam, N.W. Lukacs, et al. 2000. Chemokines and innate immunity. Rev. Immunogenet. 2:339-358.
101. Marcotik, A., G. Dasic, A. Gagro, et al. 1999. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin. Exp. Immunol. 115:329-334.
102. Markotic, A., K. Anderson, and C. Smaljohn. 2001. The possible role of cytokines, chemokines and their receptors in immunopathogenesis of HFRS and HPS. Presented at the 5th International Conference on Hemorrhagic Fever with Renal Syndrome (HFRS), Hantavirus Pulmonary Syndrome (HPS), and Hantaviruses. Annecy, France, 13-16 June.
103. Mazanec, M.B., J.G. Nedrud, and M.E. Lamm. 1987. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J. Virol. 61:2624-2626.
104. Mazanec, M.B., C.S. Kaetzel, M.E. Lamm, et al. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. U.S.A. 89:6901-6905.
105. McBride, B.M., and K.A. Ward. 1987. Herpes simplex-specific IgG subclass response in herpes keratitis. J. Med. Virol. 21:179-189.
106. Mori, M., A.L. Rothman, I. Kurane, et al. 1999. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 179:295-302.
107. Morris, G.E., R.M. Coleman, J.M. Best, et al. 1985. Persistance of serum IgA antibodies to herpes simplex, varicella zoster, cytomegalovirus, and rubella virus detected by enzyme-linked immunosorbent assay. J. Med. Virol. 16:343-349.
108. Morzunov S.P., H. Feldmann, C.F. Spiropoulou, et al. 1995. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J. Virol. 69:1980-1983.
109. Nakamura, T., R. Yanagihara, C.J. Gibbs, Jr., et al. 1985. Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice. J. Infect. Dis. 151:691-697.
110. Nakamura, T., R. Yanagihara, C.J. Gibbs, Jr., et al. 1985. Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection. Arch. Virol. 86:109-120.
111. Nathan, C.F., H.W. Murray, M.E. Wiebe, et al. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
112. Nichol, S.T., C.F. Spiropoulou, S.P. Morzunov, et al. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917.
113. Nolte, K.B., R.M. Feddersen, K. Foucar, et al. 1995. Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent. Hum. Pathol. 26:110-120.
114. Ozaki, H., H. Hayashi, S.A. Vinores, et al. 1997. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp. Eye Res. 64:505-517.
115. Padula, P.J., S.B. Colavecchia, V.P. Martinez, et al. 2000. Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J. Clin. Microb. 38:3029-3035.
116. Papa, A., A.M. Johnson, P.C. Stockton, et al. 1998. Retrospective serological and genetic study of the distribution of hantavirus in Greece. J. Med. Virol. 55:321-327.
117. Papadimitrou, M. 1995. Hantavirus nephropathy. Kidney Int. 48:887-902.
118. Partridge, C.A., C.J. Horvath, P.J. Del Vecchio, et al. 1992. Influence of extracellular matrix in tumor necrosis factor-induced increase in endothelial permeability. Am. J. Physiol. 263:L627-L633.
119. Pensiero, M.N., J.B. Sharefkin, C.W. Dieffenbach, et al. 1992. Hantaan virus infection of human endothelial cells. J. Virol. 66:5929-5936.
120. Peters, C.J. 1998. Hantavirus pulmonary syndrome in the americas. In W.M. Sheld, W.A. Craig, and J.M. Hughes (eds), Emerging Infections 2. ASM Press, Washington, DC, pp. 17-64.
121. Plyusnin, A., J. Horling, M. Karneva, et al. 1997. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 35:1090-1096.
122. Plyusnin, A., K. Nemirov, N. Apekina, et al. 1999. Dobrava virus in Russia. Lancet 353:207.
123. Plyusnin, A., and S.P. Morzunov. 2001. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. CTMI 256:47-75.
124. Ruo, S.L., A. Sanchez, L.H. Elliott, et al. 1991. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch. Virol. 119:1-11.
125. Rot, A., M. Krieger, T. Brunner, et al. 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489-1495.
126. Renegar, K.B., and P.A. Small, Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
127. Sallberg, M., H. Norder, and L.O. Magnius. 1990. Comparison of class and subclass distribution of antibodies to the Hepatitis B core and Be antigens in chronic Hepatitis B. J. Med. Virol. 30:1-6.
128. Schall, T.J., K. Bacon, K.J. Toy, et al. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671.
129. Schmaljohn, C.S., S.E. Hasty, J.M. Dalrymple, et al. 1985. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227:1041-1044.
130. Schmaljohn, C.S., Y.K. Chu, A.L. Schmaljohn, et al. 1990. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:3162-3170.
131. Schmaljohn, C.S., and J.W. Hooper. 2001. Bunyaviridae: The viruses and their replication. In B.N. Fields, D.M. Knipe, and P.M. Howley (eds.), Field's Virology. Lippincott-Raven, Philadelphia, pp. 1581-1602.
132. Sears, D.W., and J.E. Christiaansen. 1985. In P. Herkart and E. Martz (eds), Mechanisms of Cell-Mediated Cytotoxicity II. Plenum, New York, pp. 509-524.
133. Sheshberadaran, H., B. Niklasson and E.A. Tkachenko. 1988. Antigenic relationship between hantaviruses analysed by immunoprecipitation. J. Gen. Virol. 69:2645-2651.
134. Senger, D.R., S.J. Galli, A.M. Dvorak, et al. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
135. Settergren, B., C. Ahlm, P. Juto, et al. 1991. Specific Puumala IgG virus half a century after haemorrhagic fever with renal syndrome. Lancet 338:66.
136. Sozzani, S., W. Luini, M. Molino, et al. 1991. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J. Immunol. 147:2215-2221.
137. Stein-Streilein, J., P.L. Witte, J.W. Streilein, et al. 1985. Local cellular defenses in influenza-infected lungs. Cell Immunol. 95:234-246.
138. Stolpen, A.H., E.C. Guinan, W. Fiers, et al. 1986. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123:16-24.
139. Sundstrom, J.B., L.K. McMullan, C.F. Spiropoulou, et al. Hantavirus infection induces the expression of RANTES and IP-10 without increased permeability in human lung microvascular endothelial cells. J. Virol. 75:6070-6085.
140. Tamura, M., H. Asada, K. Kondo, et al. 1989. Pathogenesis of Hantaan virus in mice. J. Gen. Virol. 70:2897-2906.
141. Tanishita, O., Y. Takahashi, Y. Okuno, et al. 1986. Persistent infection of rats with hemorrhagic fever with renal syndrome virus and their antibody responses. J. Gen. Virol. 67:2819-2824.
142. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193:1311-1318.
143. Temonen, M., J. Mustonen, H. Helin, et al. 1996. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: An immunohistochemical study. Clin. Immunol. Immunopathol. 78:47-55.
144. Tew, J.G., R.P. Phipps, and T.E. Mandel. 1980. The maintenance and regulation of the humoral immune response: Persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol. Rev. 53:175-201.
145. Torfason, E.G., C.B. Reimer, and H.L. Keyserling. 1987. Subclass restriction of human enterovirus antibodies. J. Clin. Microbiol. 25:1376-1379.
146. Tracey, K.J., B. Beutler, S.F. Lowry, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
147. Ulrich, R., A. Lundkvist, H. Meisel, et al. 1998. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 16:272-280.
148. Van Campen, H. 1994. Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro. Arch. Virol. 136:439-446.
149. van der Poll, T., J. Jansen, M. Levi, et al. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1988.
150. Vapalahti, O., H. Kallio-Kokko, E.M. Salonen, et al. 1992. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: Evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J. Gen. Virol. 73:829-838.
151. Vapalahti, O., H. Kallio-Kokko, A. Narvanen, et al. 1995. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J. Med. Virol. 46:293-303.
152. Vapalahti, O., A. Lundkvist, and A. Vaheri. 2001. Human immune response, host genetics, and severity of disease. CTMI 256:153-170.
153. Wagner, D.K., P. Muelenaer, F.W. Henderson, et al. 1989. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glicoproteins after first, second, and third infections. J. Clin. Microbiol. 27:589-592.
154. Wang, M., C. Rossi, and C. S. Schmaljohn. 1993. Expression of non-conserved regions of the S genome segments of three hantaviruses: Evaluation of the expressed polypeptides for diagnosis of haemorrhagic fever with renal syndrome. J. Gen. Virol. 74:1115-1124.
155. Welliver, R.C., M. Sun, D. Rinaldo, et al. 1986. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J. Pediatr. 109:776-780.
156. Yamada, T., B. Hjelle, R. Lanzi, et al. 1995. Antibody responses to Four Comers hantavirus infections in the deer mouse (Peromyscus maniculatus): Identification of an immunodominant region of the viral nucleocapsid protein. J. Virol. 69:1939-1943.
157. Yanagihara, R., and D.J. Silverman. 1990. Experimental infection of human vascular endothelial cells by pathogenic and non-pathogenic hantaviruses. Arch. Virol. 111:281-286.
158. Yao, Z.Q., W.S. Yang, X.F. Bai, et al. 1987. Identification of hemorrhagic fever virus (EHFV) in human leukocytes. Chung Hua I Hsueh Tsa Chih 67:497-498.
159. Yao, Z.-Q., W.-S. Yang, W.-B. Zhang, et al. 1989. The distribution and duration of Hantaan virus in the body fluids of patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 160:218-224.
160. Yoshimatsu, K., Y.C. Yoo, R. Yoshida, et al. 1993. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch. Virol. 130:365-376.
161. Yoshimatsu, K., J. Arikawa, M. Tamura, et al. 1996. Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies. J. Gen. Virol. 77:687-694.
162. Zaki, S.R., R.W. Grrer, L.M. Coffield, et al. 1995. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.
163. Zhang, X.L., X.H. Wang, C.Z. Liu, et al. 1987. Detection of viral antigens in various organs in 14 fatal cases of epidemic hemorrhagic fever. Chung Hua Nei Ko Tsa Chih 26:461-463.
164. Zoller, L., J. Scholz, R. Stohwasser, et al. 1989. Immunoblot analysis of the serological response in hantavirus infections. J. Med. 27:231-237.
165. Zoller, L., S. Yang, P. Gott, et al. 1993. A novel μ-capture EIA based recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. J. Clin. Microb. 31:1194-1199.